| |
Control (n = 12)
|
SGLT2 (n = 12)
|
|---|
|
Body weight (g)
|
733.3 ± 5.3
|
664.0 ± 9.2*
|
|
Tibia length (mm)
|
39.1 ± 0.1
|
39.0 ± 0.1
|
|
Epididymal fat weight (g)
|
6.4 ± 0.2
|
7.0 ± 0.3
|
|
Mesenteric fat weight (g)
|
12.3 ± 0.2
|
11.8 ± 0.2
|
|
Perirenal fat weight (g)
|
56.2 ± 1.0
|
53.8 ± 1.3
|
|
Subcutaneous fat weight (g)
|
69.0 ± 1.5
|
52.7 ± 2.2*
|
|
Liver weight (g)
|
29.5 ± 0.74
|
28.6 ± 0.35
|
|
Left ventricular weight (mg)
|
1465 ± 44
|
1363 ± 16#
|
-
Control SHRcp fed control diet; SGLT2 SHRcp fed control diet containing empagliflozin. Values are mean ± SEM. Statistical analysis was performed by unpaired Student’s t test
-
# P < 0.05, * P < 0.01 versus control
